Living with Terminal Prostate Cancer: A Lesson in Finding Joy in Everyday Moments
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
#cancer #mentalhealth #prostatecancer
👇👇👇
@kill-bait.bsky.social
@kill-bait.bsky.socialLiving with Terminal Prostate Cancer: A Lesson in Finding Joy in Everyday Moments
🤖 IA: It's not clickbait ✅
👥 Users: It's not clickbait ✅
#cancer #mentalhealth #prostatecancer
👇👇👇
@newsramp.comKairos Pharma reports Phase 2 interim data showing ENV-105 plus apalutamide achieved 17.7 months median PFS vs. 2 months for apalutamide alone in metastatic castration-resistant prostate cancer (P=0.0008). Trial completion targeted by Q4 2027. #ProstateCancer #Oncology
@vcclibrary.bsky.socialEfficacy and Safety of Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Non-BRCA Mutation Subgroup of Patients with Metastatic Castration-resistant #ProstateCancer in the PROpel Trial. euoncology.europeanurology.com/article/S258...
@vcclibrary.bsky.socialAnalysis of quality-adjusted time without symptoms or toxicity (Q-TWiST) in patients with metastatic hormone-sensitive #ProstateCancer from the ARASENS trial. www.ejcancer.com/article/S095...
@isev.org🆕New in #JEV🆕Longitudinally Monitoring Prostate Cancer Bone Metastasis and Treatment Response via Circulating Extracellular Vesicles #extracellularvesicles #iquidbiopsy #prostatecancer #bonemetastasis isevjournals.onlinelibrary.wiley.com/doi/epdf/10....
@petermaccc.bsky.socialNew hope for advanced prostate cancer: Peter Mac researchers have uncovered how cancer cells evade the immune system in bone and identified a potential target for future treatments.
Read more: www.petermac.org/about-us/new...
@scienceinvancouver.comA new study identified biomarkers that predict which patients with advanced #ProstateCancer are most likely to benefit from a combination of radioligand therapy and immunotherapy.
🤔 See the work from Drs. Sofie Tolmeijer & Alex Wyatt at the @vchresearch.bsky.social: https://bit.ly/4jx7WrP
@renalurologynews.bsky.socialThe PACE-A phase 3 trial presented at #ASTRO found the efficacy of stereotactic body radiotherapy for low- to intermediate-risk #ProstateCancer appears similar to radical prostatectomy
Read more: https://bit.ly/4e1PPqv
@oncoalert.bsky.socialA Great start to #FlorenceOncology26 🇮🇹 with WARMING UP: Exploring New Treatment Strategies and future Advances in Oncology!!
Hope you are here to join us in Florence Italy to experience firsthand some great presentations and discussions in #BreastCancer , #ProstateCancer , #HeanandNeckCancer & More
@vcclibrary.bsky.socialPrevalence of osteoporosis and low bone mass in men with #ProstateCancer: a systematic review and meta-analysis. link.springer.com/article/10.1...
@ancan501c3.bsky.socialOne of many #prostatecancer virtual support groups
Low/Intermediate Risk #ActiveSurveillance Prostate Cancer meets weekly on the 1st-4th Wednesday of the month. Free & drop-in; Join directly here:
https://www.gotomeet.me/AnswerCancer
@cancerpatientseu.bsky.social📣 Have you or someone close to you been diagnosed with metastatic #prostatecancer?
CPE is inviting patients, families & carers to share their experiences of tests, scans and new treatments in a short survey.
🕐 10 min
Available in: 🇬🇧 🇫🇷 🇮🇹 🇪🇸 🇩🇪
@alliance-org.bsky.socialNow enrolling! Dr. Deepak Kilari from @MedicalCollege is now enrolling @ALLIANCE-org A032302, the ASPIRE trial to see if adding chemo to hormone therapy improves survival in men with metastatic #prostatecancer. To learn more, visit http://bit.ly/AllianceA032302. #clinicaltrials #PCSM
@uksurgeons.bsky.socialRadiotherapy ‘comparable’ to surgery for certain prostate cancer patients www.icr.ac.uk/about-us/icr... #prostatecancer #surgery
@stopthestigma.bsky.socialFarmer uses $5,000 ram to start conversations about prostate cancer #prostatecancer #awareness #agriculture
@artera.aiFrom localized to metastatic #ProstateCancer, where can AI-based biomarkers help inform care?
This @Medscape feature explores the growing clinical evidence behind #ArteraAI across the prostate cancer care continuum and beyond.
Read more: buff.ly/QZPlToC
@ancan501c3.bsky.socialTODAY: You're trying to navigate your life AND your disease. Others with a more complex #ProstateCancer, who have been in the same boat, will be there to help in our #virtualsupport group
1st and 3rd Mondays every month at 8pm EST / 5pm PST
@stemcellsciencenews.com📢 New in @cp-cellrepmed.bsky.social: Study findings identify EZH2-PI3K/mTORC1 signaling as a therapeutic vulnerability in phenotypically plastic #ProstateCancer and reveal Tristetraprolin as a contributor to therapy response.
Read the #OpenAccess article here: https://bit.ly/4z8WoQf
@artera.aiThat’s a wrap on #ASTRO26!
Thank you to everyone who connected with the Artera team throughout the meeting. We enjoyed the conversations and the opportunity to spend time with the radiation oncology community.
Until next year! 👋
@evertonthesitcom.bsky.socialPut me on the no view side today, but thats my treatments done until next month now.
Be an early night tonight 🤮
Get checked lads!
